Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Health Catalyst, Inc. Director's Dealing 2019

Jul 25, 2019

33681_dirs_2019-07-24_422eeae7-bd64-4656-813d-b008e0c1957c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-24

Reporting Person: Sanders Dale (Chief Operating Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 60078 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $2.46 2022-01-04 Common Stock (50000.0) Direct
Stock Option (Right to Buy) $10.3 2025-11-09 Common Stock (202500.0) Direct
Stock Option (Right to Buy) $10.8 2028-09-27 Common Stock (500000.0) Direct
Stock Option (Right to Buy) $15.84 2029-02-05 Common Stock (300000.0) Direct

Footnotes

F1: This stock option award is fully vested and exercisable.

F2: 25% of the shares vested on October 28, 2016; and the remaining 75% vest in 36 equal monthly installments thereafter.

F3: The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option will satisfy the time-based vesting condition on September 25, 2019 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition is satisfied upon the earlier of the Company's initial public offering or a sale of the Company.

F4: The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option will satisfy the time-based vesting condition on February 5, 2020 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition is satisfied upon the earlier of the Company's initial public offering or a sale of the Company.